SuperworthEledon Pharmaceuticals market cap ELDN
Share price times shares outstanding: what the whole company sells for, since 2014.
- Today, Oct 23, 2026
- $186.9M
- Highest close in our data
- $343.8M
- Nov 2014
Eledon Pharmaceuticals is worth $186.9M at the close on Oct 23, 2026, at $2.30 a share.
That is down 10% over the last year and up 161% over five years.
Its highest close in our data was $343.8M in Nov 2014.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $186.9M | $97.1M | $314.2M | +95% |
| 2025 | $95.9M | $86.3M | $288.5M | −63% |
| 2024 | $259.9M | $37.3M | $278.4M | +497% |
| 2023 | $43.6M | $25.5M | $54.2M | +39% |
| 2022 | $31.4M | $31.4M | $63.4M | −50% |
| 2021 | $63.1M | $15.1M | $168.1M | +186% |
| 2020 | $22M | $4.5M | $36.2M | +174% |
| 2019 | $8M | $6.6M | $46.2M | −52% |
| 2018 | $16.9M | $16.9M | $74M | −41% |
| 2017 | $28.8M | $10.1M | $36.2M | +30% |
| 2016 | $22.1M | $21M | $173.3M | −89% |
| 2015 | $196.9M | $196.9M | $338.6M | −39% |
| 2014 | $323.4M | $318.9M | $343.8M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Eledon Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| ELDNEledon Pharmaceuticals | $186.9M |
| NATRNatures Sunshine Products | $213.8M |
| LFVNLifevantage | $73.4M |
| ARVNArvinas | $477.3M |
| SPROSpero Therapeutics | $64.6M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| ATNMActinium Pharmaceuticals | $47.8M |
| COLLCollegium Pharmaceutical | $747.5M |
| Peer median | $523.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Eledon Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.